Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Diane Slafsky and 340B Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Diane Slafsky and 340B Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 2: HRSA Responds to J&J’s Rebate Proposal; Capitol Hill Inquiries; State-Level Battles

31:08
 
Share
 

Manage episode 444048780 series 3600977
Content provided by Diane Slafsky and 340B Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Diane Slafsky and 340B Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In episode 2, host Ted Slafsky, along with Will Newton and Bella Czajkowski, recap major news impacting the 340B program, including the future of manufacturer efforts to convert 340B to a rebate, Sen. Bill Cassidy’s latest inquiry into two drugmakers, pushback from bipartisan House members to the rebate proposal federal 340B legislation and key state developments.

Key Topics Covered

  • Johnson & Johnson recently dropped its 340B rebate proposal amid strong enforcement threats from the federal government, but manufacturer efforts to convert the 340B program to a rebate model are likely to continue. The crew discusses the implications of the government’s response to J&J’s proposal and what it means for other manufacturer efforts to pursue 340B rebate models. They also explain how 340B rebates may arise in response to an inquiry from influential Republican Sen. Bill Cassidy, who has often been critical of 340B program growth.

  • Key lawmakers with a more favorable view of the 340B program have also been engaged in a flurry of legislative and policy making activity. The crew shares insights into a bipartisan House letter opposing 340B rebates and the status of a Senate bill to restore 340B discounts to contract pharmacies. They also touch on the implications of a children’s Medicaid enrollment bill with 340B provisions and two major updates on state-level battles over contract pharmacy access laws.

What’s Next for Inside 340B Report

In future episodes, the team will provide an inside look at the topics and issues impacting the stakeholders in the 340B drug discount program. Listen to fascinating conversations between 340B Report editors and reporters on what they are covering and why it is important.

Stay tuned for more episodes biweekly! 🎧 Subscribe to Inside 340B Report on your favorite podcast platform and follow us on YouTube for video discussions.

Special thanks to 340B Report Ultra Diamond sponsors who made this episode possible including: AIDS Healthcare Foundation, The Alinea Group, Avita Care Solutions, Maxor, RxParadigm, RxStrategies and Verity Solutions.

Thank you for joining us on this journey. We look forward to bringing you valuable insights and discussions on the 340B program. For more information, visit 340BReport.com.

Special discount for YouTube and podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code: PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.

  continue reading

19 episodes

Artwork
iconShare
 
Manage episode 444048780 series 3600977
Content provided by Diane Slafsky and 340B Report. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Diane Slafsky and 340B Report or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In episode 2, host Ted Slafsky, along with Will Newton and Bella Czajkowski, recap major news impacting the 340B program, including the future of manufacturer efforts to convert 340B to a rebate, Sen. Bill Cassidy’s latest inquiry into two drugmakers, pushback from bipartisan House members to the rebate proposal federal 340B legislation and key state developments.

Key Topics Covered

  • Johnson & Johnson recently dropped its 340B rebate proposal amid strong enforcement threats from the federal government, but manufacturer efforts to convert the 340B program to a rebate model are likely to continue. The crew discusses the implications of the government’s response to J&J’s proposal and what it means for other manufacturer efforts to pursue 340B rebate models. They also explain how 340B rebates may arise in response to an inquiry from influential Republican Sen. Bill Cassidy, who has often been critical of 340B program growth.

  • Key lawmakers with a more favorable view of the 340B program have also been engaged in a flurry of legislative and policy making activity. The crew shares insights into a bipartisan House letter opposing 340B rebates and the status of a Senate bill to restore 340B discounts to contract pharmacies. They also touch on the implications of a children’s Medicaid enrollment bill with 340B provisions and two major updates on state-level battles over contract pharmacy access laws.

What’s Next for Inside 340B Report

In future episodes, the team will provide an inside look at the topics and issues impacting the stakeholders in the 340B drug discount program. Listen to fascinating conversations between 340B Report editors and reporters on what they are covering and why it is important.

Stay tuned for more episodes biweekly! 🎧 Subscribe to Inside 340B Report on your favorite podcast platform and follow us on YouTube for video discussions.

Special thanks to 340B Report Ultra Diamond sponsors who made this episode possible including: AIDS Healthcare Foundation, The Alinea Group, Avita Care Solutions, Maxor, RxParadigm, RxStrategies and Verity Solutions.

Thank you for joining us on this journey. We look forward to bringing you valuable insights and discussions on the 340B program. For more information, visit 340BReport.com.

Special discount for YouTube and podcast listeners. 340B Report is the indispensable source for news and intelligence on the 340B program. First-time subscribers may subscribe now using coupon code: PODCAST25. Not ready to subscribe? Sign up for a 15-day free trial.

  continue reading

19 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play